
Patient-Reported Well-Being in Value-Based Routine Care Using Tildrakizumab: 52-week Interim Data of the Phase IV ...
Introduction Psoriatic disease is a chronic inflammatory condition, with a complex pathophysiology, affecting over 60 million people worldwide.1–3 Beyond its physical impact on the skin, plaque psoriasis can profoundly affect patients’ psychological and …